Clovis Oncology to Present at the 8th Annual SVB Leerink Healthcare Conference
BOULDER, Colo.--(BUSINESS WIRE)--Feb 22, 2019--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 11:00 a.m. Eastern time. The conference will be held at the Lotte New York Palace in New York City.
A live webcast of the presentation and Q&A session can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190222005067/en/
CONTACT: Anna Sussman
KEYWORD: UNITED STATES NORTH AMERICA COLORADO NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS ONCOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES FINANCE
SOURCE: Clovis Oncology, Inc.
Copyright Business Wire 2019.
PUB: 02/22/2019 08:00 AM/DISC: 02/22/2019 08:01 AM